Back to search
Refractory Gout
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Gout trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Gout trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus pegloticase Q2W w…
This trial is to assess efficacy, safety, blood levels and bodily effects of up to 2 dose levels of intravenous (IV) pegloticase (KRYSTEXXA) infusions at every…